- Home
- KWR vs CLDX Comparison
KWR vs CLDX Comparison
Compare KWR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWR
- CLDX
- Stock Information
- Founded
- KWR 1918
- CLDX N/A
- Country
- KWR United States
- CLDX United States
- Employees
- KWR N/A
- CLDX N/A
- Industry
- KWR Major Chemicals
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- KWR Industrials
- CLDX Health Care
- Exchange
- KWR Nasdaq
- CLDX Nasdaq
- Market Cap
- KWR 2.2B
- CLDX 1.9B
- IPO Year
- KWR 1985
- CLDX 2008
- Fundamental
- Price
- KWR $140.28
- CLDX $24.34
- Analyst Decision
- KWR Strong Buy
- CLDX Buy
- Analyst Count
- KWR 4
- CLDX 10
- Target Price
- KWR $149.25
- CLDX $43.80
- AVG Volume (30 Days)
- KWR 129.6K
- CLDX 866.0K
- Earning Date
- KWR 10-30-2025
- CLDX 11-10-2025
- Dividend Yield
- KWR 1.48%
- CLDX N/A
- EPS Growth
- KWR N/A
- CLDX N/A
- EPS
- KWR N/A
- CLDX N/A
- Revenue
- KWR $1,864,242,000.00
- CLDX $2,599,000.00
- Revenue This Year
- KWR $2.57
- CLDX N/A
- Revenue Next Year
- KWR $4.45
- CLDX N/A
- P/E Ratio
- KWR N/A
- CLDX N/A
- Revenue Growth
- KWR 0.08
- CLDX N/A
- 52 Week Low
- KWR $95.91
- CLDX $14.40
- 52 Week High
- KWR $175.17
- CLDX $29.05
- Technical
- Relative Strength Index (RSI)
- KWR 53.32
- CLDX 44.59
- Support Level
- KWR $130.39
- CLDX $22.10
- Resistance Level
- KWR $143.25
- CLDX $26.85
- Average True Range (ATR)
- KWR 5.96
- CLDX 1.20
- MACD
- KWR 0.93
- CLDX -0.30
- Stochastic Oscillator
- KWR 64.63
- CLDX 36.70
About KWR Quaker Houghton
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.